Real-life Evaluation of the Safety and Performance of EUROTEKNIKA Dental Implants

Launched by EUROTEKNIKA · May 10, 2022

Keywords

ClinConnect Summary

This clinical trial is looking at the safety and effectiveness of EUROTEKNIKA dental implants in people who have lost some or all of their teeth. The study aims to understand how well these implants work in real-life situations. If you're 18 years or older, have completed your bone growth, and are missing teeth, you might be eligible to participate. You would need to agree to join the study and either be getting a new EUROTEKNIKA implant or have already received one before 2017.

Participants in this trial can expect to have their experience with the dental implants closely monitored. The study will help gather important information about how these implants perform over time and whether they are safe for patients. However, some people, such as those who are pregnant or have certain health issues, may not be eligible to take part. Overall, this trial aims to improve dental care for individuals needing implants by providing valuable insights into their use.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patient aged 18 or over
• • Patient who has completed bone growth
• • Patient informed and agreeing to participate in the study
• • Partially or totally edentulous patient who will be implanted with the EUROTEKNIKA dental implant (for the prospective cohort)
• • Patient to benefit from the placement of an implant for the creation of a single crown (for the prospective cohort)
• • Patient implanted with the EUROTEKNIKA dental implant before 2017 (for the retrospective cohort)
• • Patient having benefited from the placement of an implant for the creation of a single crown (for the retrospective cohort)
• Exclusion Criteria:
• • Pregnant or breastfeeding women (for the prospective cohort)
• • Patient with bone disease in the cervico-facial region
• • Patient refusing to participate in the study
• • Patient with at least one contraindication to implantation (for the prospective cohort)
• • Patient to benefit from the placement of an implant with immediate or early loading (for the prospective cohort)
• • Patient to benefit from the placement of an implant for the support of the bridge, piles, attachment (for the prospective cohort)
• • Patient having benefited from the placement of an implant with immediate or early loading (for the retrospective cohort)
• • Patient having benefited from the placement of an implant for the support of the bridge, piles, attachment (for the retrospective cohort)